Suitable Mouse Model to Study Dynamics of West Nile Virus Infection in Culex quinquefasciatus Mosquitoes.

West Nile Virus (WNV) poses a significant global public health threat as a mosquito-borne pathogen. While laboratory mouse models have historically played a crucial role in understanding virus biology, recent research has focused on utilizing immunocompromised models to study arboviruses like dengue and Zika viruses, particularly their interactions with Aedes aegypti mosquitoes. However, there has been a shortage of suitable mouse models for investigating WNV and St. Louis encephalitis virus interactions with their primary vectors, Culex spp. mosquitoes. Here, we establish the AG129 mouse (IFN α/ß/γ R-/-) as an effective vertebrate model for examining mosquito-WNV interactions. Following intraperitoneal injection, AG129 mice exhibited transient viremia lasting several days, peaking on the second or third day post-infection, which is sufficient to infect Culex quinquefasciatus mosquitoes during a blood meal. We also observed WNV replication in the midgut and dissemination to other tissues, including the fat body, in infected mosquitoes. Notably, infectious virions were present in the saliva of a viremic AG129 mouse 16 days post-exposure, indicating successful transmission capacity. These findings highlight the utility of AG129 mice for studying vector competence and WNV-mosquito interactions.

Arboviruses in Mammals in the Neotropics: A Systematic Review to Strengthen Epidemiological Monitoring Strategies and Conservation Medicine.

Arthropod-borne viruses (arboviruses) are a diverse group of ribonucleic acid (RNA) viruses, with the exception of African swine fever virus, that are transmitted by hematophagous arthropods to a vertebrate host. They are the important cause of many diseases due to their ability to spread in different environments and their diversity of vectors. Currently, there is no information on the geographical distribution of the diseases because the routes of transmission and the mammals (wild or domestic) that act as potential hosts are poorly documented or unknown. We conducted a systematic review from 1967 to 2021 to identify the diversity of arboviruses, the areas, and taxonomic groups that have been monitored, the prevalence of positive records, and the associated risk factors. We identified forty-three arboviruses in nine mammalian orders distributed in eleven countries. In Brazil, the order primates harbor the highest number of arbovirus records. The three most recorded arboviruses were Venezuelan equine encephalitis, Saint Louis encephalitis and West Nile virus. Serum is the most used sample to obtain arbovirus records. Deforestation is identified as the main risk factor for arbovirus transmission between different species and environments (an odds ratio of 1.46 with a 95% confidence interval: 1.34-1.59). The results show an increase in the sampling effort over the years in the neotropical region. Despite the importance of arboviruses for public health, little is known about the interaction of arboviruses, their hosts, and vectors, as some countries and mammalian orders have not yet been monitored. Long-term and constant monitoring allows focusing research on the analysis of the interrelationships and characteristics of each component animal, human, and their environment to understand the dynamics of the diseases and guide epidemiological surveillance and vector control programs. The biodiversity of the Neotropics should be considered to support epidemiological monitoring strategies.

Retrospective Investigation in Horses with Encephalitis Reveals Unnoticed Circulation of West Nile Virus in Brazil.

During these past years, several studies have provided serological evidence regarding the circulation of West Nile virus (WNV) in Brazil. Despite some reports, much is still unknown regarding the genomic diversity and transmission dynamics of this virus in the country. Recently, genomic monitoring activities in horses revealed the circulation of WNV in several Brazilian regions. These findings on the paucity of genomic data reinforce the need for prompt investigation of WNV infection in horses, which may precede human cases of encephalitis in Brazil. Thus, in this study, we retrospectively screened 54 suspicious WNV samples collected between 2017 and 2020 from the spinal cord and brain of horses with encephalitis and generated three new WNV genomes from the Ceará and Bahia states, located in the northeastern region of Brazil. The Bayesian reconstruction revealed that at least two independent introduction events occurred in Brazil. The first introduction event appears to be likely related to the North American outbreak, and was estimated to have occurred in March 2013.The second introduction event appears to have occurred in September 2017 and appears to be likely related to the South American outbreak. Together, our results reinforce the importance of increasing the priority of WNV genomic monitoring in equines with encephalitis in order to track the dispersion of this emerging pathogen through the country.

Serosurvey in Two Dengue Hyperendemic Areas of Costa Rica Evidence Active Circulation of WNV and SLEV in Peri-Domestic and Domestic Animals and in Humans.

Costa Rica harbors several flaviviruses, including Dengue (DENV), Zika (ZIKV), West Nile virus (WNV), and Saint Louis encephalitis virus (SLEV). While DENV and ZIKV are hyperendemic, previous research indicates restricted circulation of SLEV and WNV in animals. SLEV and WNV seroprevalence and high transmission areas have not yet been measured. To determine the extents of putative WNV and SLEV circulation, we sampled peri-domestic and domestic animals, humans, and mosquitoes in rural households located in two DENV and ZIKV hyperendemic regions during the rainy and dry seasons of 2017-2018 and conducted plaque reduction neutralization test assay for serology (PRNT) and RT-PCR for virus detection. In Cuajiniquil, serological evidence of WNV and SLEV was found in equines, humans, chickens, and wild birds. Additionally, five seroconversion events were recorded for WNV (2 equines), SLEV (1 human), and DENV-1 (2 humans). In Talamanca, WNV was not found, but serological evidence of SLEV circulation was recorded in equines, humans, and wild birds. Even though no active viral infection was detected, the seroconversion events recorded here indicate recent circulation of SLEV and WNV in these two regions. This study thus provides clear-cut evidence for WNV and SLEV presence in these areas, and therefore, they should be considered in arboviruses differential diagnostics and future infection prevention campaigns.

Serosurvey of West Nile virus (WNV) in free-ranging raptors from Brazil.

West Nile virus (WNV) is a mosquito-borne Flavivirus that can affect birds, horses, and humans, and is the only zoonotic Flavivirus that has been identified in six continents. In Brazil, until 2010, there was no evidence of WNV circulation. Recently, the virus was isolated from a horse with encephalitis, and the first human cases were registered in Brazil. Despite that, there is still no information on the enzootic cycle of this virus in birds or wildlife. This study aimed to investigate whether there is evidence of WNV circulation among wild birds from Southern Brazil. For this, we used free-living wild raptors (live-trapped or rescued) as potential sentinels to investigate the presence of WNV antibodies using ELISA and plaque reduction neutralization test (PRNT) assay. In addition, the presence of nucleic acids from Flavivirus family members was investigated. None of the birds sampled presented clinical findings compatible with WNV. Of the 200 serum samples from birds of prey belonging to 21 species, ten (5%) were positive for the presence of WNV antibodies on ELISA testing. The PRNT test did not confirm the ELISA results, but indicated that three birds had possibly been exposed to Saint Louis encephalitis virus (SLEV). All samples were negative for Flavivirus RNA. The results presented here evince the need for permanent surveillance for emerging flaviviruses in Brazil, as well as for a contingency policy in the case of human/animal outbreaks, particularly in high-risk areas.

The Regulation of Flavivirus Infection by Hijacking Exosome-Mediated Cell-Cell Communication: New Insights on Virus-Host Interactions.

The arthropod-borne flaviviruses are important human pathogens, and a deeper understanding of the virus-host cell interaction is required to identify cellular targets that can be used as therapeutic candidates. It is well reported that the flaviviruses hijack several cellular functions, such as exosome-mediated cell communication during infection, which is modulated by the delivery of the exosomal cargo of pro- or antiviral molecules to the receiving host cells. Therefore, to study the role of exosomes during flavivirus infections is essential, not only to understand its relevance in virus-host interaction, but also to identify molecular factors that may contribute to the development of new strategies to block these viral infections. This review explores the implications of exosomes in flavivirus dissemination and transmission from the vector to human host cells, as well as their involvement in the host immune response. The hypothesis about exosomes as a transplacental infection route of ZIKV and the paradox effect or the dual role of exosomes released during flavivirus infection are also discussed here. Although several studies have been performed in order to identify and characterize cellular and viral molecules released in exosomes, it is not clear how all of these components participate in viral pathogenesis. Further studies will determine the balance between protective and harmful exosomes secreted by flavivirus infected cells, the characteristics and components that distinguish them both, and how they could be a factor that determines the infection outcome.

West nile virus infections are here! are we prepared to face another flavivirus epidemic?

Abstract Emerging arthropod-borne viruses (arboviruses), such as chikungunya and Zika viruses, are a major threat to public health in countries like Brazil where biodiversity is high and medical care is sometimes precarious. West Nile fever is a disease caused by the West Nile Virus (WNV), an RNA virus belonging to the Flaviviridae family. It is transmitted by infected mosquitoes to numerous animals like birds, reptiles and mammals, including human and non-human primates. In the last decade, the number of reported cases of WNV infection in humans and animals has increased in the Americas. Circulation of WNV in forests and rural areas in Brazil has been detected based on serological surveys and, in 2014, the first case of West Nile fever was confirmed in a patient from Piauí State. In 2018, the virus was isolated for the first time from a horse from a rural area in the state of Espírito Santo presenting with a neurological disorder; this raises the possibility that other cases of WNV encephalitis may have occurred without clinical recognition and without laboratory diagnosis by specific assays. The imminent WNV outbreak poses a challenge for Brazilian clinicians and researchers. In this review, we summarize the basic biological and ecological characteristics of this virus and the clinical presentation and treatment of febrile illnesses caused by WNV. We also discuss the epidemiological aspects, prophylaxis of WNV infections, and monitoring strategies that could be applied in the possibility of a WNV outbreak in Brazil.

New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.

The development and production of viral vaccines, in general, involve several steps that need the monitoring of viral load throughout the entire process. Applying a 2-step quantitative reverse transcription real time PCR assay (RT-qPCR), viral load can be measured and monitored in a few hours. In this context, the development, standardization and validation of a RT-qPCR test to quickly and efficiently quantify yellow fever virus (YFV) in all stages of vaccine production are extremely important. To serve this purpose we used a plasmid construction containing the NS5 region from 17DD YFV to generate the standard curve and to evaluate parameters such as linearity, precision and specificity against other flavivirus. Furthermore, we defined the limits of detection as 25 copies/reaction, and quantification as 100 copies/reaction for the test. To ensure the quality of the method, reference controls were established in order to avoid false negative results. The qRT-PCR technique based on the use of TaqMan probes herein standardized proved to be effective for determining yellow fever viral load both in vivo and in vitro, thus becoming a very important tool to assure the quality control for vaccine production and evaluation of viremia after vaccination or YF disease.

Production and diagnostic application of recombinant domain III of West Nile envelope protein in Brazil

INTRODUCTION: West Nile virus (WNV) is a flavivirus with a natural cycle involving mosquitoes and birds. Over the last 11 years, WNV has spread throughout the Americas with the imminent risk of its introduction in Brazil. METHODS: Envelope protein domain III of WNV (rDIII) was bacterially expressed and purified. An enzyme-linked immunosorbent assay with WNV rDIII antigen was standardized against mouse immune fluids (MIAFs) of different flavivirus. RESULTS: WNV rDIII reacted strongly with St. Louis encephalitis virus (SLEV) MIAF but not with other flaviviruses. CONCLUSIONS: This antigen may be a potentially useful tool for serologic diagnosis and may contribute in future epidemiological surveillance of WNV infections in Brazil.

Serological detection of West Nile virus in horses and chicken from Pantanal, Brazil

In an effort to detect West Nile virus (WNV) in Brazil, we sampled serum from horses and chickens from the Pantanal region of the state of Mato Grosso and tested for flavivirus-reactive antibodies by blocking ELISA. The positive samples were further confirmed for serological evidence of WNV infection in three (8%) of the 38 horses and one (3.2%) of the 31 chickens using an 80% plaque-reduction neutralisation test (PRNT80). These results provide evidence of the circulation of WNV in chickens and horses in Pantanal.

Serological detection of St. Louis encephalitis virus and West Nile virus in equines from Santa Fe, Argentina

St. Louis encephalitis virus (SLEV) and West Nile virus (WNV) present ecological and antigenic similarities and are responsible for serious human diseases. In addition, WNV is a significant pathogen in terms of equine health. The purpose of our study was to analyse the seroprevalence of SLEV and WNV in equine sera collected in Santa Fe Province, Argentina. The seroprevalence determined using the plaque reduction neutralisation test was 12.2% for SLEV, 16.2% for WNV and 48.6% for a combination of both viruses. These results provide evidence of the co-circulation of SLEV and WNV in equines in Santa Fe.

Stable expression and potential use of West Nile virus envelope glycoproteins preM/E as antigen in diagnostic tests

West Nile virus (WNV) envelope glycoproteins preM/E were stably expressed in baby hamster kidney cells and tested as antigen in a fluorescent antibody assay for WNV antibodies. Sera from horses, mice and chicken immunized with an inactivated WNV vaccine and, less consistently, sera from horses acutely infected with WNV, reacted specifically with viral antigens present in preM/E-expressing cells.

Stable expression and potential use of west nile virus envelope glycoproteins preM/E as antigen in diagnostic tests.

West Nile virus (WNV) envelope glycoproteins preM/E were stably expressed in baby hamster kidney cells and tested as antigen in a fluorescent antibody assay for WNV antibodies. Sera from horses, mice and chicken immunized with an inactivated WNV vaccine and, less consistently, sera from horses acutely infected with WNV, reacted specifically with viral antigens present in preM/E-expressing cells.

Stable expression and potential use of West Nile virus envelope glycoproteins preM/E as antigen in diagnostic tests

West Nile virus (WNV) envelope glycoproteins preM/E were stably expressed in baby hamster kidney cells and tested as antigen in a fluorescent antibody assay for WNV antibodies. Sera from horses, mice and chicken immunized with an inactivated WNV vaccine and, less consistently, sera from horses acutely infected with WNV, reacted specifically with viral antigens present in preM/E-expressing cells.

O vírus do Nilo Ocidental: [revisão] / West Nile virus: [review]

O vírus do Nilo Ocidental (WNV) é um flavivírus que se mantém na natureza em ciclos alternados de infecção, em pássaros e mosquitos hematófagos, principalmente do gênero Culex. A infecção natural já foi demonstrada em mais de 200 espécies de aves, sendo que a susceptibilidade à infecção e à doença varia amplamente. Os corvídeos e os passeriformes são particularmente susceptíveis, desenvolvendo altos níveis de viremia e também elevada mortalidade. Ocasionalmente, a infecção pode ser transmitida para mamíferos pela picada de mosquitos que realizaram o repasto sangüíneo em aves virêmicas. Os humanos e os eqüinos estão entre os mamíferos mais susceptíveis e freqüentemente desenvolvem um quadro febril, que pode ser acompanhado de infecção neurológica e meningoencefalite fatal. A infecção pelo WNV, inicialmente identificada em Uganda (1937), durante décadas ficou restrita ao Norte da África, ao Oeste da Ásia, ao Oriente Médio e à Europa Mediterrânea, com relatos de casos isolados ou pequenos surtos de doença em humanos e eqüinos. Em 1999, o vírus foi introduzido em Nova Iorque, nos Estados Unidos, onde causou mortalidade de milhares de aves e infectou centenas de pessoas, levando 21 a óbito. A partir de então, a infecção se disseminou por praticamente todos os Estados norte-americanos, causando infecção e/ou doença em mais de 27 mil pessoas (1100 mortes), eqüinos (mais de 25.000 casos) e provocando mortalidade e redução da população de algumas espécies de aves silvestres. Evidências da infecção têm sido progressivamente detectadas em várias espécies animais no México, na América Central, no Caribe e no Norte da América do Sul, indicando a sua disseminação na direção sul. O WNV foi identificado como o agente de meningoencefalite fatal em três eqüinos na Argentina (2006), onde parece estar presente em pássaros nativos pelo menos desde 2005. Pesquisadores e autoridades sanitárias brasileiras da área humana e animal temem que a infecção seja introduzida...

West Nile virus (WNV) is a Flavivirus maintained in nature through alternate cycles of infection in wild birds and haematophagus mosquitoes, mainly Culex sp. Natural infection by WNV has been demonstrated in more than 200 bird species, which present variable susceptibility to infection and disease. Corvids and passeriformes are particularly susceptible and develop high levels of viremia and mortality. Occasionally, the virus may be transmitted to mammals by mosquitoes feeding previously on viremic birds. Human and horses are highly susceptible to WNV infection and often develop fever, which may be followed by neurological infection and fatal meningoencephalitis. Originally identified in Uganda (1937), WNV infection remained for decades restricted to North Africa, East Asia, Middle East and Mediterranean Europe. In these areas, isolated cases of human and horse disease, or small outbreaks were occasionally reported. In 1999, the virus was introduced in New York, USA, where it caused mortality in thousands of wild and captive birds and infected hundreds of people, killing 21. Thereafter, the infection rapidly spread out over the US territory, causing thousands of human infections (more than 27.000 - around 1100 deaths) and equine infections (more than 25.000 cases). WNV infection has also been detected in wild and domestic birds, horses and other mammals across Mexico, Central America and the Caribbean, and northern South America, indicating its dissemination southwards. In 2006, WNV was first identified as the agent of fatal neurological disease in three horses in Argentina, where it has been shown to be circulating in wild birds at least since 2005. Brazilian's human and animal health authorities are concerned with a possible introduction of the virus in the country, where it would find ideal ecological conditions for transmission and spread. This article presents a brief review on the main epidemiological and clinico-pathological...

O vírus do Nilo Ocidental

West Nile virus (WNV) is a Flavivirus maintained in nature through alternate cycles of infection in wild birds and haematophagus mosquitoes, mainly Culex sp. Natural infection by WNV has been demonstrated in more than 200 bird species, which present variable susceptibility to infection and disease. Corvids and passeriformes are particularly susceptible and develop high levels of viremia and mortality. Occasionally, the virus may be transmitted to mammals by mosquitoes feeding previously on viremic birds. Human and horses are highly susceptible to WNV infection and often develop fever, which may be followed by neurological infection and fatal meningoencephalitis. Originally identified in Uganda (1937), WNV infection remained for decades restricted to North Africa, East Asia, Middle East and Mediterranean Europe. In these areas, isolated cases of human and horse disease, or small outbreaks were occasionally reported. In 1999, the virus was introduced in New York, USA, where it caused mortality in thousands of wild and captive birds and infected hundreds of people, killing 21. Thereafter, the infection rapidly spread out over the US territory, causing thousands of human infections (more than 27.000 - around 1100 deaths) and equine infections (more than 25.000 cases). WNV infection has also been detected in wild and domestic birds, horses and other mammals across Mexico, Central America and the Caribbean, and northern South America, indicating its dissemination southwards. In 2006, WNV was first identified as the agent of fatal neurological disease in three horses in Argentina, where it has been shown to be circulating in wild birds at least since 2005. Brazilian's human and animal health authorities are concerned with a possible introduction of the virus in the country, where it would find ideal ecological conditions for transmission and spread. This article presents a brief review on the main epidemiological and clinico-pathological aspects of WNV infection, with emphasis to human, horse and avian infections.

O vírus do Nilo Ocidental (WNV) é um flavivírus que se mantém na natureza em ciclos alternados de infecção, em pássaros e mosquitos hematófagos, principalmente do gênero Culex. A infecção natural já foi demonstrada em mais de 200 espécies de aves, sendo que a susceptibilidade à infecção e à doença varia amplamente. Os corvídeos e os passeriformes são particularmente susceptíveis, desenvolvendo altos níveis de viremia e também elevada mortalidade. Ocasionalmente, a infecção pode ser transmitida para mamíferos pela picada de mosquitos que realizaram o repasto sangüíneo em aves virêmicas. Os humanos e os eqüinos estão entre os mamíferos mais susceptíveis e freqüentemente desenvolvem um quadro febril, que pode ser acompanhado de infecção neurológica e meningoencefalite fatal. A infecção pelo WNV, inicialmente identificada em Uganda (1937), durante décadas ficou restrita ao Norte da África, ao Oeste da Ásia, ao Oriente Médio e à Europa Mediterrânea, com relatos de casos isolados ou pequenos surtos de doença em humanos e eqüinos. Em 1999, o vírus foi introduzido em Nova Iorque, nos Estados Unidos, onde causou mortalidade de milhares de aves e infectou centenas de pessoas, levando 21 a óbito. A partir de então, a infecção se disseminou por praticamente todos os Estados norte-americanos, causando infecção e/ou doença em mais de 27 mil pessoas (1100 mortes), eqüinos (mais de 25.000 casos) e provocando mortalidade e redução da população de algumas espécies de aves silvestres. Evidências da infecção têm sido progressivamente detectadas em várias espécies animais no México, na América Central, no Caribe e no Norte da América do Sul, indicando a sua disseminação na direção sul. O WNV foi identificado como o agente de meningoencefalite fatal em três eqüinos na Argentina (2006), onde parece estar presente em pássaros nativos pelo menos desde 2005. Pesquisadores e autoridades sanitárias brasileiras da área humana e animal temem que a infecção seja introduzida no país, onde provavelmente encontraria condições ecológicas para a sua disseminação e manutenção. Este artigo apresenta uma breve revisão dos principais aspectos epidemiológicos e clínico-patológicos da infecção pelo WNV, com ênfase na infecção de humanos, aves e eqüinos.

O vírus do Nilo Ocidental

West Nile virus (WNV) is a Flavivirus maintained in nature through alternate cycles of infection in wild birds and haematophagus mosquitoes, mainly Culex sp. Natural infection by WNV has been demonstrated in more than 200 bird species, which present variable susceptibility to infection and disease. Corvids and passeriformes are particularly susceptible and develop high levels of viremia and mortality. Occasionally, the virus may be transmitted to mammals by mosquitoes feeding previously on viremic birds. Human and horses are highly susceptible to WNV infection and often develop fever, which may be followed by neurological infection and fatal meningoencephalitis. Originally identified in Uganda (1937), WNV infection remained for decades restricted to North Africa, East Asia, Middle East and Mediterranean Europe. In these areas, isolated cases of human and horse disease, or small outbreaks were occasionally reported. In 1999, the virus was introduced in New York, USA, where it caused mortality in thousands of wild and captive birds and infected hundreds of people, killing 21. Thereafter, the infection rapidly spread out over the US territory, causing thousands of human infections (more than 27.000 - around 1100 deaths) and equine infections (more than 25.000 cases). WNV infection has also been detected in wild and domestic birds, horses and other mammals across Mexico, Central America and the Caribbean, and northern South America, indicating its dissemination southwards. In 2006, WNV was first identified as the agent of fatal neurological disease in three horses in Argentina, where it has been shown to be circulating in wild birds at least since 2005. Brazilian's human and animal health authorities are concerned with a possible introduction of the virus in the country, where it would find ideal ecological conditions for transmission and spread. This article presents a brief review on the main epidemiological and clinico-pathological aspects of WNV infection, with emphasis to human, horse and avian infections.

O vírus do Nilo Ocidental (WNV) é um flavivírus que se mantém na natureza em ciclos alternados de infecção, em pássaros e mosquitos hematófagos, principalmente do gênero Culex. A infecção natural já foi demonstrada em mais de 200 espécies de aves, sendo que a susceptibilidade à infecção e à doença varia amplamente. Os corvídeos e os passeriformes são particularmente susceptíveis, desenvolvendo altos níveis de viremia e também elevada mortalidade. Ocasionalmente, a infecção pode ser transmitida para mamíferos pela picada de mosquitos que realizaram o repasto sangüíneo em aves virêmicas. Os humanos e os eqüinos estão entre os mamíferos mais susceptíveis e freqüentemente desenvolvem um quadro febril, que pode ser acompanhado de infecção neurológica e meningoencefalite fatal. A infecção pelo WNV, inicialmente identificada em Uganda (1937), durante décadas ficou restrita ao Norte da África, ao Oeste da Ásia, ao Oriente Médio e à Europa Mediterrânea, com relatos de casos isolados ou pequenos surtos de doença em humanos e eqüinos. Em 1999, o vírus foi introduzido em Nova Iorque, nos Estados Unidos, onde causou mortalidade de milhares de aves e infectou centenas de pessoas, levando 21 a óbito. A partir de então, a infecção se disseminou por praticamente todos os Estados norte-americanos, causando infecção e/ou doença em mais de 27 mil pessoas (1100 mortes), eqüinos (mais de 25.000 casos) e provocando mortalidade e redução da população de algumas espécies de aves silvestres. Evidências da infecção têm sido progressivamente detectadas em várias espécies animais no México, na América Central, no Caribe e no Norte da América do Sul, indicando a sua disseminação na direção sul. O WNV foi identificado como o agente de meningoencefalite fatal em três eqüinos na Argentina (2006), onde parece estar presente em pássaros nativos pelo menos desde 2005. Pesquisadores e autoridades sanitárias brasileiras da área humana e animal temem que a infecção seja introduzida no país, onde provavelmente encontraria condições ecológicas para a sua disseminação e manutenção. Este artigo apresenta uma breve revisão dos principais aspectos epidemiológicos e clínico-patológicos da infecção pelo WNV, com ênfase na infecção de humanos, aves e eqüinos.

O vírus do Nilo Ocidental

West Nile virus (WNV) is a Flavivirus maintained in nature through alternate cycles of infection in wild birds and haematophagus mosquitoes, mainly Culex sp. Natural infection by WNV has been demonstrated in more than 200 bird species, which present variable susceptibility to infection and disease. Corvids and passeriformes are particularly susceptible and develop high levels of viremia and mortality. Occasionally, the virus may be transmitted to mammals by mosquitoes feeding previously on viremic birds. Human and horses are highly susceptible to WNV infection and often develop fever, which may be followed by neurological infection and fatal meningoencephalitis. Originally identified in Uganda (1937), WNV infection remained for decades restricted to North Africa, East Asia, Middle East and Mediterranean Europe. In these areas, isolated cases of human and horse disease, or small outbreaks were occasionally reported. In 1999, the virus was introduced in New York, USA, where it caused mortality in thousands of wild and captive birds and infected hundreds of people, killing 21. Thereafter, the infection rapidly spread out over the US territory, causing thousands of human infections (more than 27.000 - around 1100 deaths) and equine infections (more than 25.000 cases). WNV infection has also been detected in wild and domestic birds, horses and other mammals across Mexico, Central America and the Caribbean, and northern South America, indicating its dissemination southwards. In 2006, WNV was first identified as the agent of fatal neurological disease in three horses in Argentina, where it has been shown to be circulating in wild birds at least since 2005. Brazilian's human and animal health authorities are concerned with a possible introduction of the virus in the country, where it would find ideal ecological conditions for transmission and spread. This article presents a brief review on the main epidemiological and clinico-pathological aspects of WNV infection, with emphasis to human, horse and avian infections.

O vírus do Nilo Ocidental (WNV) é um flavivírus que se mantém na natureza em ciclos alternados de infecção, em pássaros e mosquitos hematófagos, principalmente do gênero Culex. A infecção natural já foi demonstrada em mais de 200 espécies de aves, sendo que a susceptibilidade à infecção e à doença varia amplamente. Os corvídeos e os passeriformes são particularmente susceptíveis, desenvolvendo altos níveis de viremia e também elevada mortalidade. Ocasionalmente, a infecção pode ser transmitida para mamíferos pela picada de mosquitos que realizaram o repasto sangüíneo em aves virêmicas. Os humanos e os eqüinos estão entre os mamíferos mais susceptíveis e freqüentemente desenvolvem um quadro febril, que pode ser acompanhado de infecção neurológica e meningoencefalite fatal. A infecção pelo WNV, inicialmente identificada em Uganda (1937), durante décadas ficou restrita ao Norte da África, ao Oeste da Ásia, ao Oriente Médio e à Europa Mediterrânea, com relatos de casos isolados ou pequenos surtos de doença em humanos e eqüinos. Em 1999, o vírus foi introduzido em Nova Iorque, nos Estados Unidos, onde causou mortalidade de milhares de aves e infectou centenas de pessoas, levando 21 a óbito. A partir de então, a infecção se disseminou por praticamente todos os Estados norte-americanos, causando infecção e/ou doença em mais de 27 mil pessoas (1100 mortes), eqüinos (mais de 25.000 casos) e provocando mortalidade e redução da população de algumas espécies de aves silvestres. Evidências da infecção têm sido progressivamente detectadas em várias espécies animais no México, na América Central, no Caribe e no Norte da América do Sul, indicando a sua disseminação na direção sul. O WNV foi identificado como o agente de meningoencefalite fatal em três eqüinos na Argentina (2006), onde parece estar presente em pássaros nativos pelo menos desde 2005. Pesquisadores e autoridades sanitárias brasileiras da área humana e animal temem que a infecção seja introduzida no país, onde provavelmente encontraria condições ecológicas para a sua disseminação e manutenção. Este artigo apresenta uma breve revisão dos principais aspectos epidemiológicos e clínico-patológicos da infecção pelo WNV, com ênfase na infecção de humanos, aves e eqüinos.